Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (CML) is a type of cancer that starts in the bone marrow and leads to the production of too many white blood cells. It usually progresses slowly and mainly affects adults. The disease is characterized by a specific genetic mutation called the Philadelphia chromosome. Treatment options and prognosis for CML have improved significantly in recent years due to the development of targeted drugs. Early diagnosis and appropriate treatment are crucial for managing this condition.